AI Business: AI-based drug development startups have raised $2.1bn in the past six monthsUlrik Kristensen2021-09-09T14:42:18+01:00July 21st, 2021|
The Science Advisory Board: AI drug development startups raised $2.1B in 1st half of 2021Ulrik Kristensen2021-09-09T14:35:17+01:00July 19th, 2021|
AI Drug Development Startups Raised $2.1B in H1 2021Ulrik Kristensen2021-07-09T10:34:33+01:00July 6th, 2021|
The Science Advisory Board: Royalties Challenge Risk and Reward in AI Drug DevelopmentUlrik Kristensen2021-06-07T13:49:03+01:00June 7th, 2021|
Royalties Challenge Risk and Reward in AI Drug DevelopmentUlrik Kristensen2021-07-07T09:38:39+01:00May 27th, 2021|
Charles River Acquired Distributed Bio – Here’s What it Means for the AI EcosystemUlrik Kristensen2021-06-07T13:50:55+01:00January 14th, 2021|
